文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

帕瑞昔布通过功能性调节肺内募集CD11bloLy6Chi单核细胞减轻呼吸机相关性肺损伤

Paracoxib Alleviates Ventilator-Induced Lung Injury Through Functional Modulation of Lung-Recruited CD11bloLy6Chi Monocytes.
PubMed 文献 · Shock · 2021-01-01
一句话结论小鼠模型中,通气前1小时静脉给予帕瑞昔布30 mg/kg可减轻LPS加损伤性通气所致的肺损伤,机制涉及减少肺募集CD11bloLy6Chi单核细胞及其氧化应激和炎症因子产生。

该研究为小鼠模型实验,先腹腔注射LPS 20 ng,再行损伤性机械通气(潮气量30 mL/kg,呼气末正压0 cmH2O);亚组在通气前1小时静脉给予帕瑞昔布30 mg/kg。结果显示,帕瑞昔布明显减轻LPS加损伤性通气所致的严重肺组织损伤、氧合障碍和肺水肿,并减少肺募集CD11bloLy6Chi单核细胞数量,降低其活性氧、一氧化氮、MHC-II表达和炎症细胞因子产生,而对组织驻留CD64+肺泡巨噬细胞无影响。作者认为,帕瑞昔布减轻肺募集Ly6Chi单核细胞的氧化应激和炎症,可能部分解释COX-2抑制在呼吸机相关性肺损伤中的有益作用。

要点

  • 小鼠模型中,通气前1小时静脉给予帕瑞昔布30 mg/kg,明显减轻LPS加损伤性通气(潮气量30 mL/kg,呼气末正压0 cmH2O)所致的肺组织损伤、氧合障碍和肺水肿。
  • 帕瑞昔布减少肺募集CD11bloLy6Chi单核细胞数量,对组织驻留CD64+肺泡巨噬细胞无影响。
  • 帕瑞昔布降低CD11bloLy6Chi单核细胞的活性氧、一氧化氮、MHC-II表达和炎症细胞因子产生。
  • 作者认为,帕瑞昔布减轻肺募集Ly6Chi单核细胞的氧化应激和炎症,可能部分解释COX-2抑制在呼吸机相关性肺损伤中的有益作用。
  • 该研究为小鼠模型实验,结果不能直接外推至临床患者。

适用人群与场景

  • 小鼠模型:腹腔注射LPS 20 ng后接受损伤性机械通气(潮气量30 mL/kg,呼气末正压0 cmH2O)。
  • 对照组小鼠接受生理盐水且不接受通气。

处置流程与药物剂量

  • 帕瑞昔布30 mg/kg,静脉给药,于通气前1小时给予。

研究设计与关键结果

  • 研究类型为小鼠模型实验;干预为帕瑞昔布30 mg/kg静脉给药(通气前1小时),对照为生理盐水且不通气。
  • LPS加损伤性通气导致严重肺组织损伤、氧合障碍和肺水肿,帕瑞昔布治疗后上述表现明显减轻。
  • 流式细胞术显示,帕瑞昔布减少肺募集CD11bloLy6Chi单核细胞数量,对组织驻留CD64+肺泡巨噬细胞无影响。
  • 帕瑞昔布降低CD11bloLy6Chi单核细胞的活性氧、一氧化氮、MHC-II表达和炎症细胞因子产生。

证据类型、等级与局限

  • 证据类型:小鼠模型实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠模型实验,帕瑞昔布30 mg/kg静脉给药在通气前1小时使用的结果不能直接改变急诊或ICU临床实践。
  • 作者认为,帕瑞昔布减轻肺募集Ly6Chi单核细胞的氧化应激和炎症,可能部分解释COX-2抑制在呼吸机相关性肺损伤中的有益作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Lung-recruited Ly6Chi monocytes had been shown to be involved in ventilator-induced lung injury (VILI). Our present study aimed to investigate whether the cyclooxygenase-2 (COX-2) inhibition modulates the function of lung-recruited Ly6Chi monocytes in a mouse model of VILI.

METHODS: Mice were exposed to lipopolysaccharide (LPS; 20 ng) intraperitoneally prior to injurious mechanical ventilation (Vt = 30 mL/kg, PEEP = 0 cmH2O). A subgroup of mice was treated with intravenous parecoxib (30 mg/kg), a COX-2 inhibitor, 1 h prior to ventilation. Control mice received saline and were not ventilated. At the end of the experiment, blood gas analysis was performed and lung tissue was collected for histological assessment. Flow cytometry was employed to quantify the different populations of lung monocytes/macrophages and their function. Isolated Ly6Chi cells were used to measure the intracellular concentrations of reactive oxygen species (ROS) and nitric oxide (NO) by fluorescent probes, and cytokine production by cytometric bead array.

RESULTS: Exposure to LPS and injurious ventilation was associated with severe lung histological damage, oxygenation impairment, and pulmonary edema; all of which were largely attenuated following the treatment of parecoxib. Furthermore, flow cytometry analysis revealed that parecoxib caused a reduction in the number of the lung-recruited CD11bloLy6Chi monocytes while there was no effect on tissue-resident CD64+ alveolar macrophages. In addition, the production of oxidative stress products (ROS, NO), MHC-II expression, and inflammatory cytokines in response to LPS and VILI in CD11bloLy6Chi monocytes was ameliorated by parecoxib.

CONCLUSION: Parecoxib-induced alleviation of oxidative stress and inflammation in lung-recruited Ly6Chi monocytes may partly explain the beneficial action of COX-2 inhibition in VILI.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhang C, Hu S, Zosky GR, et al. Paracoxib Alleviates Ventilator-Induced Lung Injury Through Functional Modulation of Lung-Recruited CD11bloLy6Chi Monocytes. Shock. 2021. PMID: 32590697. doi:10.1097/SHK.0000000000001591

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。